Quantcast

Latest Clinical research Stories

2014-08-21 08:29:22

Patient recruitment-retention leader MediciGlobal expands its international team as the company continues to invest in best in class talent PHILADELPHIA and LONDON, Aug. 21, 2014 /PRNewswire/ -- MediciGlobal Ltd., a global leader in patient recruitment and retention for clinical trials, today announced the appointment of Linda Capsey, PhD as Vice President Project Management and Innovation. With more than 20 years industry experience, Dr. Capsey joins MediciGlobal's dynamic...

2014-08-21 08:29:20

PHILADELPHIA, Aug. 21, 2014 /PRNewswire/ -- ACI Clinical (www.aciclinical.com) announces a new, standards-based platform for independent Data Monitoring Committees. http://photos.prnewswire.com/prnvar/20131120/PH19940LOGO Using this solution, trial sponsors can save up to 30 percent over industry standard costs and receive the same expertise that has made ACI an industry leader in committee services. Leveraging a decade of DMC experience (initial design, member recruitment and...

2014-08-21 08:28:33

ENGLEWOOD, Colo., Aug. 21, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a delay in the data analysis of the STEP Study due to the discovery by the independent Clinical Research Organization (CRO) that the study drug (both Ampion(TM) and the placebo) were, during shipment to the clinical sites, exposed to lower temperatures than permitted by the drug specifications. http://photos.prnewswire.com/prnvar/20120516/MM09116LOGO Michael Macaluso, Ampio's...

2014-08-21 08:28:27

Mid and High Level Doses Demonstrate Statistically Significant Improvement in Cellulite Across All Endpoints; Nearly 70% of Mid and High Dose Patients Satisfied or Very Satisfied with Results CHESTERBROOK, Pa., Aug. 21, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced positive results from a randomized, double-blind Phase 2a study of collagenase clostridium histolyticum (or CCH) for the treatment of edematous...

2014-08-20 23:08:43

The August issue of Atlantic Information Services’s Specialty Pharmacy News offers coverage of recent developments in the biosimilars specialty pharmacy segment, including the Food and Drug Administration’s recent acceptance of a biosimilar application, the first step towards approval. Washington, DC (PRWEB) August 20, 2014 Biosimilars, which are similar versions of branded biologic drugs that are approved through an abbreviated process, could reap billions in health care savings. The...

2014-08-20 16:25:31

SOUTH PLAINFIELD, N.J., Aug. 20, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will participate at two upcoming investor conferences: http://photos.prnewswire.com/prnvar/20010919/PTCLOGO - FBR 1(st) Annual Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 3(rd) - Citi's 9(th) Annual Biotech Conference at The Mandarin Oriental Boston on Thursday, September 4(th) In addition, management will present a company...

2014-08-20 08:28:40

BISHOPS STORTFORD, England, August 20, 2014 /PRNewswire/ -- Dotmatics data analysis and visualisation tool proven essential in Prof. Cooper's team's quest for finding new 'superbug' antibiotics Dotmatics [http://www.dotmatics.com ], a leading provider of scientific informatics solutions and services, announced today that Prof. Cooper's renowned Medicinal Chemistry and Drug Development research group at the Institute for Molecular Bioscience, University of Queensland has...

2014-08-20 08:27:41

ENGLEWOOD, Colo., Aug. 20, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that in response to requests from patients and physicians, the company has performed an analysis of the available data from both portions of the study. On October 7, 2013, following an IDRC determination "that there was a treatment dosage (of Optina(TM)) that was demonstrating a potentially beneficial anatomic effect." The company initiated an open label extension study using the...

2014-08-19 23:13:32

With more than 50 years of combined experience, expert presenters Sherri Hubby and Brian Nugent will share insights that can be used to establish Risk Based Monitoring Plans, including triggers for return to 100% source data verification. Even better, they'll show attendees how to proactively identify and manage risks to trials with methods that can immediately be implemented and used. Falls Church, VA (PRWEB) August 19, 2014 Managing Risk for Clinical Trials: Incorporating Quality by...

2014-08-19 23:13:18

On August 12, Wellspring Pharmaceutical Corporation announced that one lot of IPM Wound Gel is recalled due to microbial contamination. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 19, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on IPM Wound Gel. Wellspring Pharmaceutical Corporation...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.